XENE short interest
Xenon Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 6,041,487 |
|---|---|
| Change vs prior report | -403,328 (-6.3%) |
| Change over six months | +24.5% |
| Days to cover | 1.58 (sector: 3.78) |
| Average daily volume | 3,834,835 |
| Rank in Healthcare | #741 of 922 by days to cover |
XENE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 6,041,487 | -6.3% | 1.58 | 3,834,835 |
| 2026-09-15 | 6,444,815 | +1.6% | 12.22 | 527,345 |
| 2026-08-31 | 6,344,135 | +11.9% | 9.09 | 698,275 |
| 2026-08-14 | 5,668,994 | +5.3% | 9.16 | 618,635 |
| 2026-07-31 | 5,384,476 | -15.0% | 7.33 | 734,532 |
| 2026-07-15 | 6,337,096 | +1.3% | 3.56 | 1,778,010 |
| 2026-06-30 | 6,257,737 | +42.0% | 2.96 | 2,112,290 |
| 2026-06-15 | 4,408,157 | +9.0% | 3.20 | 1,376,477 |
| 2026-05-29 | 4,044,948 | +5.5% | 2.94 | 1,377,667 |
| 2026-05-15 | 3,833,400 | -7.6% | 4.04 | 947,846 |
| 2026-04-30 | 4,149,067 | -14.5% | 4.62 | 898,777 |
| 2026-04-15 | 4,854,352 | +0.1% | 5.38 | 902,450 |
| 2026-03-31 | 4,851,044 | -11.0% | 3.54 | 1,368,500 |
| 2026-03-13 | 5,451,476 | -1.5% | 1.70 | 3,210,098 |
| 2026-02-27 | 5,533,096 | +2.9% | 6.77 | 816,874 |
| 2026-02-13 | 5,379,792 | -2.9% | 7.38 | 728,885 |
| 2026-01-30 | 5,541,753 | +3.2% | 6.57 | 844,032 |
| 2026-01-15 | 5,371,266 | -9.4% | 4.36 | 1,232,230 |
| 2025-12-31 | 5,927,441 | +3.6% | 8.23 | 719,882 |
| 2025-12-15 | 5,720,672 | -2.9% | 7.12 | 803,381 |
| 2025-11-28 | 5,889,334 | -2.5% | 7.36 | 800,250 |
| 2025-11-14 | 6,043,619 | +4.5% | 7.37 | 819,858 |
| 2025-10-31 | 5,785,686 | -5.9% | 7.30 | 792,372 |
| 2025-10-15 | 6,148,669 | -20.2% | 8.10 | 759,555 |
| 2025-09-30 | 7,705,812 | +9.4% | 9.64 | 799,511 |
import finzdata as yf
yf.Ticker("XENE").short_interest # every report since 2017
yf.Client().short_interest(["XENE"], start="2018-01-01")Healthcare short interest · XENE price history · Who owns XENE · All short interest